Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05256563 · ClinicalTrials.gov registry record

A Biomarker for Personalized Care in Post-Stroke Spatial Neglect

A clinical trial of Stroke and Spatial Neglect, sponsored by VA Office of Research and Development.

Active
Registry status
45
Enrollment target
1
Study location

NCT05256563 is a study of Stroke and Spatial Neglect that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 45 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05256563, a study of Stroke and Spatial Neglect, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

More than 30,000 Veterans are hospitalized for stroke each year, and in the critical first months of recovery, at least half are disabled by abnormal 3-D spatial function (spatial neglect). Their self-care, mobility, and ability to return home are severely limited.

Conditions Studied

Study Locations (1)

Georgia

  • Atlanta VA Medical and Rehab Center, Decatur, GA - Decatur

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2021-09-01
Est. Completion 2027-07-31

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05256563

The ClinicalTrials.gov registry entry for NCT05256563 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT05256563 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05256563 about?

NCT05256563 is a clinical study titled "A Biomarker for Personalized Care in Post-Stroke Spatial Neglect". More than 30,000 Veterans are hospitalized for stroke each year, and in the critical first months of recovery, at least half are disabled by abnormal 3-D spatial function (spatial neglect). Their self-care, mobility, and ability to return home are severely limited.

What is the current status of trial NCT05256563?

This trial is currently active not recruiting. The enrollment target is 45 participants. The study started on 2021-09-01. Estimated completion is 2027-07-31.

What conditions does trial NCT05256563 study?

This clinical trial studies the following conditions: Stroke, Spatial Neglect.

Who is sponsoring clinical trial NCT05256563?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05256563 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.